{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:29:02Z","timestamp":1776119342159,"version":"3.50.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":2529,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.adengl.2012.10.012","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T02:15:42Z","timestamp":1376360142000},"page":"654-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Update on the Classification and Treatment of Localized Scleroderma"],"prefix":"10.1016","volume":"104","author":[{"given":"I.","family":"Bielsa Marsol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adengl.2012.10.012_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea. Part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/rheumatology\/27.4.286","article-title":"An epidemiological study of scleroderma in the West Midlands","volume":"27","author":"Silman","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0015","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0020","first-page":"171","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0025","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.adengl.2012.10.012_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0035","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"May Clin Proc"},{"key":"10.1016\/j.adengl.2012.10.012_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1085-5629(98)80058-8","article-title":"Classification and epidemiology of scleroderma","volume":"17","author":"Mayes","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.adengl.2012.10.012_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1085-5629(98)80059-X","article-title":"Localized scleroderma","volume":"17","author":"Tuffanelli","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.adengl.2012.10.012_bib0050","first-page":"283","article-title":"Morph\u00e9es: classification et pris en charge","volume":"125","author":"Salmon-Ehr Eschard","year":"1998","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1085-5629(99)80019-4","article-title":"Morphea and localized scleroderma in children","volume":"18","author":"Vierra","year":"1999","journal-title":"Semin Cut Med Surg"},{"key":"10.1016\/j.adengl.2012.10.012_bib0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/sder.2001.23093","article-title":"Localized and systemic scleroderma","volume":"20","author":"Hawk","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.adengl.2012.10.012_bib0065","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2006.07.004","article-title":"Systemic and localized scleroderma","volume":"24","author":"Chung","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.sder.2007.02.005","article-title":"Deep morphea","volume":"26","author":"Bielsa","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.adengl.2012.10.012_bib0075","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000246685","article-title":"Atrophoderma Pasini-Pierini is a primary atrophic abortive morphea","volume":"190","author":"Kencka","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2012.10.012_bib0085","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2003.11.088","article-title":"Is superficial morphea synonymous with atrophoderma Pasini-Pierini","volume":"50","author":"Jablonska","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000372-199908000-00001","article-title":"Morphea limited to the superficial reticular dermis: an underrecognized histologic phenomenon","volume":"21","author":"McNiff","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0095","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00000372-199408000-00011","article-title":"Bullous morphea: a distinct entity","volume":"16","author":"Trattner","year":"1994","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0190-9622(94)70113-X","article-title":"Bullous morphea: clinical pathologic and immunopathologic evaluation of 13 cases","volume":"30","author":"Daoud","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-4362.2002.01360.x","article-title":"Bullous lesions in scleroderma","volume":"41","author":"Rencic","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0110","first-page":"409","article-title":"Coexistence of generalized morphea with histological changes in lichen sclerosus et atrophicus","volume":"25","author":"Sawamura","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0190-9622(80)80190-3","article-title":"Morphea and lichen sclerosus et atrophicus","volume":"3","author":"Uitto","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0120","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/archderm.1991.01680080088007","article-title":"Lichen sclerosus et atrophicus, morphea and coexistence of both diseases: histological studies using lectins","volume":"127","author":"Shono","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0125","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2133.2000.03717.x","article-title":"Genital lichen sclerosus associated with morphea or systemic sclerosis: clinical and HLA characteristics","volume":"143","author":"Farrell","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00000372-198408000-00007","article-title":"Lichen sclerosus et atrophicus is not related to morphea","volume":"6","author":"Patterson","year":"1984","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.dad.0000183679.40184.23","article-title":"Alterations of basement membrane zone and cutaneous microvasculature in morphea and extragenital lichen sclerosus","volume":"27","author":"Kowalewsky","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2133.1989.tb04171.x","article-title":"Solitary morphea profunda","volume":"120","author":"Whittaker","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1525-1470.1991.tb00936.x","article-title":"Solitary morphea profunda in a 5-year-old girl: case report and review of the literature","volume":"8","author":"Kobayashi","year":"1991","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.1993.tb00156.x","article-title":"Solitary fibrosing paraspinal plaque: solitary morphea profunda","volume":"128","author":"Kirsner","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2230.2004.01422.x","article-title":"Does solitary morphea profunda progress","volume":"29","author":"Azad","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00000372-198604000-00009","article-title":"Bullous morphea profunda","volume":"8","author":"Su","year":"1986","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1365-2133.1996.tb06334.x","article-title":"Perforating plate-like osteoma cutis in a man with solitary morphea profunda","volume":"134","author":"Ahn","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-2230.2003.01353.x","article-title":"Osteoma cutis in a lesion of solitary morphea profunda","volume":"28","author":"Julian","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0175","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1525-1470.2006.00289.x","article-title":"Deep morphea after vaccination in two young children","volume":"23","author":"Torrelo","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-4362.1995.tb01569.x","article-title":"Morphea-like reaction from vitamin K1","volume":"34","author":"Morell","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0185","first-page":"634","article-title":"Scleroderma-like patch on the thigh in infants after vitamin K injection at birth: six observations","volume":"123","author":"Bourrat","year":"1996","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archderm.1972.01620130041010","article-title":"Generalized morphea I. Histology of the dermis and subcutaneous tissue","volume":"106","author":"Fleischmajer","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2133.1979.tb01636.x","article-title":"Subcutaneous morphea: a clinical study of sixteen cases","volume":"100","author":"Person","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00000372-198110000-00003","article-title":"Morphea profunda. A new concept and a histopathologic study of 23 cases","volume":"3","author":"Su","year":"1981","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0205","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-4362.1991.tb04356.x","article-title":"Morphea profunda","volume":"30","author":"Sayama","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-4857-7_15","article-title":"Scleroderma profunda. Clinicopathological studies","volume":"455","author":"Balabanova","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0215","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2230.2002.10493.x","article-title":"Concurrent development of dermatomyositis and morphea profunda","volume":"27","author":"Park","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0220","first-page":"792","article-title":"Morphea, fasciitis and scleroderma with eosinophilia: a broad spectrum of disease [abstract]","volume":"19","author":"Caperton","year":"1976","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.012_bib0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-4362.1980.tb00283.x","article-title":"Generalized morphea with peripheral eosinophilia: fasciitis and myositis","volume":"19","author":"King","year":"1980","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0230","first-page":"171","article-title":"Generalized morphea: systemic aspects of a cutaneous disease. Description of 12 cases and review of the literature","volume":"85","author":"Bielsa","year":"1985","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.adengl.2012.10.012_bib0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00005792-199409000-00002","article-title":"Internal involvement in localized scleroderma","volume":"73","author":"Dehen","year":"1994","journal-title":"Medicine"},{"key":"10.1016\/j.adengl.2012.10.012_bib0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): Review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archderm.1987.01660270088021","article-title":"Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea","volume":"123","author":"Falanga","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0250","first-page":"19","article-title":"Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma","volume":"24","author":"Hasegawa","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0255","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archderm.1994.01690100057009","article-title":"Antigen specificity of antihistone antibodies in localized scleroderma","volume":"130","author":"Sato","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0260","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0190-9622(94)70217-9","article-title":"Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma","volume":"31","author":"Sato","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000246474","article-title":"Antihistone antibodies in scleroderma","volume":"191","author":"Parodi Drosera","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2012.10.012_bib0270","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archderm.1994.01690100053007","article-title":"Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma","volume":"130","author":"Kikuchi","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0275","series-title":"Dermatology","first-page":"585","article-title":"Systemic sclerosis (scleroderma) and related disorders","author":"Connolly","year":"2008"},{"issue":"Suppl 1","key":"10.1016\/j.adengl.2012.10.012_bib0280","first-page":"46","article-title":"Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: A new syndrome? [abstract]","volume":"1","author":"Shulman","year":"1974","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0285","first-page":"525","article-title":"Eosinophilic fasciitis: report of six cases of a newly recognized scleroderma-like syndrome","volume":"18","author":"Rodnan","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.012_bib0290","first-page":"27","article-title":"Eosinophilic fasciitis: report of 15 cases","volume":"56","author":"Michet","year":"1981","journal-title":"May Clin Proc"},{"key":"10.1016\/j.adengl.2012.10.012_bib0295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-X","article-title":"Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases","volume":"17","author":"Lakhanpal","year":"1988","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.012_bib0300","first-page":"733","article-title":"The fasciitis-morphea complex in children","volume":"146","author":"Miller","year":"1992","journal-title":"AJDC"},{"key":"10.1016\/j.adengl.2012.10.012_bib0305","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000246868","article-title":"Association of eosinophilic fasciitis, multiple morphea and antiphospholipid antibody","volume":"189","author":"Castanet","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2012.10.012_bib0310","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D36148K6D0","article-title":"Eosinophilic fasciitis\/generalized morphea overlap","volume":"15","author":"Heidary","year":"2009","journal-title":"Dermatology Online Journal"},{"key":"10.1016\/j.adengl.2012.10.012_bib0315","first-page":"493","article-title":"Eosinophilic fasciitis. A pathological study of twenty cases","volume":"96","author":"Barnes","year":"1979","journal-title":"Am J Pathol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0320","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/014107687907201017","article-title":"Eosinophilic fasciitis with megakaryocyte aplasia","volume":"72","author":"Griffin","year":"1979","journal-title":"J R Soc Med"},{"key":"10.1016\/j.adengl.2012.10.012_bib0325","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1056\/NEJM197903293001307","article-title":"Antibody-mediated aplastic anemia and diffuse fasciitis","volume":"300","author":"Hoffman","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adengl.2012.10.012_bib0330","first-page":"730","article-title":"Eosinophilic fasciitis and aplastic anemia","volume":"7","author":"Littlejohn","year":"1980","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0335","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/37.12.1358","article-title":"Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anemia associated with an eosinophilic fasciitis","volume":"37","author":"Bonnotte","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0340","first-page":"1864","article-title":"Autoimmune haemolytic anemia associated with eosinophilic fasciitis","volume":"25","author":"Garc\u00eda","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0345","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-2133.1998.02535.x","article-title":"Eosinophilic fasciitis associated with low-grade T-cell lymphoma","volume":"139","author":"Masuoka","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0350","first-page":"343","article-title":"Lymph-node-based malignant lymphoma and reactive lymphadenopathy in eosinophilic fasciitis","volume":"318","author":"Naschitz","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.adengl.2012.10.012_bib0355","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2133.2008.08647.x","article-title":"Linear morphea follows Blaschko's lines","volume":"159","author":"Weibel","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0360","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-3083.2002.00442.x","article-title":"Scleroderma en coup de sabre and progressive facial hemiatrophy. It is possible to differentiate them?","volume":"16","author":"Orozco-Covarrubias","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0365","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0375","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","article-title":"Ocular involvement in children with localized scleroderma: a multi-centre study","volume":"91","author":"Zannin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archderm.1980.01640260045011","article-title":"Disabling pansclerotic morphea of children","volume":"116","author":"D\u00edaz-P\u00e9rez","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0385","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.jaad.2004.10.881","article-title":"Disabling pansclerotic morphea: clinical presentation in two adults","volume":"53","author":"Maragh","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0390","first-page":"377","article-title":"Incapacitating pansclerotic morphea in childhood","volume":"9","author":"Ferr\u00e1ndiz","year":"1981","journal-title":"Med Cutan Ibero Lat Am"},{"key":"10.1016\/j.adengl.2012.10.012_bib0395","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1365-2133.2001.04041.x","article-title":"Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea","volume":"144","author":"Parodi","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0400","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1525-1470.2002.00033.x","article-title":"Squamous cell carcinoma in pansclerotic morphea of childhood","volume":"19","author":"Wollina","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0405","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1365-2133.2007.07866.x","article-title":"Treatment of localized scleroderma depends on the clinical subtype","volume":"156","author":"Kreuter","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0410","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea: part II. Outcome measures and treatment","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0415","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0190-9622(97)80221-6","article-title":"Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma","volume":"36","author":"Hunzelmann","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0420","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mjd.2000.108369","article-title":"Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic sclerosis","volume":"43","author":"Hulshof","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0425","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(98)70079-9","article-title":"Low-dose methotrexate in the treatment of widespread morphea","volume":"39","author":"Seyger","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0430","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archderm.141.7.847","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma","volume":"141","author":"Kreuter","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0435","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroids therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.adengl.2012.10.012_bib0440","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphea) in children","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0445","first-page":"609","article-title":"Treatment of pediatric localized scleroderma with methotrexate","volume":"33","author":"Fitch","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0450","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11845-008-0217-0","article-title":"Juvenile localized scleroderma: a retrospective review of response to systemic treatment","volume":"177","author":"Cox","year":"2008","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.adengl.2012.10.012_bib0455","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1365-2133.2008.09017.x","article-title":"Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study","volume":"160","author":"Kroft","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0460","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.1994.01690050133027","article-title":"Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients","volume":"130","author":"Joly","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0465","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1067\/mjd.2000.105165","article-title":"Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis","volume":"43","author":"Morita","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0470","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0781.2004.00080.x","article-title":"Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study","volume":"20","author":"El-Mofty","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.adengl.2012.10.012_bib0475","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(95)91843-4","article-title":"Treatment of localized scleroderma by UVA1 phototherapy","volume":"346","author":"Kerscher","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.adengl.2012.10.012_bib0480","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(97)80277-0","article-title":"High-dose UVA1 radiation therapy for localized scleroderma","volume":"36","author":"Stege","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0485","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","article-title":"Low-dose UVA phototherapy for treatment of localized scleroderma","volume":"38","author":"Kerscher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0490","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1600-0781.2001.170401.x","article-title":"Effects of low dose ultraviolet A-1 phototherapy on morphea","volume":"17","author":"Gruss","year":"2001","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.adengl.2012.10.012_bib0495","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000073093","article-title":"Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method","volume":"207","author":"De Rie","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2012.10.012_bib0500","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2008.12.013","article-title":"Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment","volume":"60","author":"Sator","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0505","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.2009.09438.x","article-title":"Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study","volume":"162","author":"Andres","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0510","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","article-title":"Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea","volume":"18","author":"Kreuter","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0515","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archderm.144.7.912","article-title":"UV-A1 phototherapy for sclerotic skin diseases: implications for optimizing patient selection and management","volume":"144","author":"Kreuter","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0520","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archderm.144.7.851","article-title":"Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototheraphy","volume":"144","author":"Wang","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0525","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1996.03890350014001","article-title":"PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients","volume":"132","author":"Kerscher","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0530","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0781.2004.00081.x","article-title":"Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis","volume":"20","author":"El-Mofty","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.adengl.2012.10.012_bib0535","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2230.2008.02890.x","article-title":"Photochemotherapy for localized morphea: effect on clinical and molecular markers","volume":"33","author":"Usmani","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0540","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0545","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1525-1470.2008.00848.x","article-title":"Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl","volume":"26","author":"Crespo","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0550","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archdermatol.2008.547","article-title":"Extracorporeal photochemotherapy for generalized deep morphea","volume":"145","author":"Neustadter","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0555","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1468-3083.2007.02403.x","article-title":"Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil","volume":"22","author":"Schlaak","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0560","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.adengl.2012.10.012_bib0565","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/rheumatology\/kep295","article-title":"A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis","volume":"48","author":"Derk","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.adengl.2012.10.012_bib0570","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archdermatol.2010.120","article-title":"Treatment of recalcitrant generalized morphea with infliximab","volume":"146","author":"Diab","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0575","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaad.2010.02.030","article-title":"Imatinib treatment of generalized localized scleroderma (morphea)","volume":"63","author":"Moinzadeh","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0580","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","article-title":"Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study","volume":"10","author":"Kroft","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0585","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","article-title":"First case series on the use of imiquimod for morphoea","volume":"153","author":"Dytoc","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0590","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09546630802132668","article-title":"Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness","volume":"20","author":"Campione","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.adengl.2012.10.012_bib0595","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.2007.07971.x","article-title":"First case series on the use of calcipotriol-betamethasone dipropionate for morphoea","volume":"157","author":"Dytoc","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0600","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2230.2008.02873.x","article-title":"Photodynamic therapy for the treatment of morphoea","volume":"33","author":"Batchelor","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.adengl.2012.10.012_bib0605","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","article-title":"An evaluation of long-term outcomes in adults with pediatric-onset morphea","volume":"146","author":"Saxton-Daniels","year":"2010","journal-title":"Arch Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157821901300173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157821901300173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:52:02Z","timestamp":1761623522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157821901300173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":121,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S157821901300173X"],"URL":"https:\/\/doi.org\/10.1016\/j.adengl.2012.10.012","relation":{},"ISSN":["1578-2190"],"issn-type":[{"value":"1578-2190","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the Classification and Treatment of Localized Scleroderma","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adengl.2012.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2012.10.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Espa\u00f1a, S.L. and AEDV.","name":"copyright","label":"Copyright"}]}}